326030.KS
SK Biopharmaceuticals Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 79,200.00
+1.28%Forward multiples
Based on analyst estimates
- P/E forward
- 39.32x
- P/E 2026E
- 19.00x
- P/E 2027E
- 15.24x
- P/E 2028E
- 11.61x
- P/S forward
- 5.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.02x
- PEG TTM
- —
- Price / book
- 5.93x
- Price / sales
- 7.03x
- Price / cash flow
- 24.08x
Enterprise value
- Enterprise value
- KRW 5.73T
- EV / sales
- 6.65x
- EV / EBITDA
- 24.26x
- EV / EBIT
- 18.88x
- Market cap
- KRW 6.06T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026